NEIGHBOURS CALLING:      Dubai      Malaysia     Nepal     Bhutan
  HOME       Contact Us      Hire Us       Domestic Airlines        Railway Enquiry     Railway Booking     Hotels Abroad
CORONAVIRUS CASUALTIES (Sept 18):- GLOBAL:- Total Cases: 3,03,56,634; Total Deaths: 9,50,625 Recovered: 2,20,46,082 BELGIUM:- Total Cases: 97,976; Total Deaths: 9,936 BRAZIL:- Total Cases: 44,57,443; Total deaths: 1,35,031 CANADA:- Total Cases: 1,40,867; Total Deaths: 9,200 CHINA:- Total Cases: 85,255 ; Total Deaths: 4,635 FRANCE:- Total Cases: 4,15,481; Total Deaths: 31,095 GERMANY:- Total Cases: 269,042; Total Deaths: 9,457 INDIA:- Total Cases: 52,14,677; Total Deaths: 84,404 INDONESIA:- Total Cases: 2,32,628; Total Deaths: 9,222 IRAN:- Total Cases: 4,13,149; Total Deaths: 23,808 ITALY:- Total Cases: 2,93,025; Total Deaths: 35,658 JAPAN:- Total Cases: 77,009; Total Deaths: 1,473 MEXICO:- Total Cases: 6,84,113; Total Deaths: 72,179 NETHERLANDS:- Total Cases: 88,073; Total Deaths: 6,266 PHILIPPINES:- Total Cases: 2,76,289; Total Deaths: 4,785 RUSSIA:- Total Cases: 10,85,281; Total Deaths: 19,061 S KOREA:- Total Cases: 22,783; Total Deaths:377 SPAIN:-Total Cases: 6,25,651; Total Deaths: 30,405 SWEDEN:- Total Cases: 87,885 Total Deaths: 5,864 SWITZERLAND:-Total Cases: 48,795; Total Deaths: 2,042 UAE:- Total Cases: 82,568; Total Deaths: 402 UK:- Total Cases: 3,81,614; Total Deaths: 41,705; US:- Total Cases: 68,74,596; Total Deaths: 202,213 - India Travel Times.Com   [Estd: 1998]       * * *    Travel, More Travel, Travel Means A Million Things     * * *    

Glenmark cuts covid drug FabiFlu's price by 27% to Rs 75 per tablet

NEW DELHI, July 23: After the Drugs Controller-General of India wrote that the price of Glenmark Pharma's version of flu medicine Favipiravir branded as FabiFlu was too high for the poor patients of coronavirus, the company has reduced the price by 27% to Rs 75 per tablet. It was earlier priced at Rs 103. The treatment cost of a 14-day regimen will come down to Rs 10,200 from Rs 14,000.

Its price is Rs 600 per tablet in Russia, Rs 378 in Japan, Rs 350 in Bangladesh and Rs 215 in China. The drug was as launched in the Indian market on June 21.

It had completed the phase 3 clinical trial in mild to moderate covid patients in India.

Glenmark had announced on June 20 that it received manufacturing and marketing approval from India's drug regulator for the drug. The DCGI granted FabifFlu approval for treatment under emergency use authorization. Under emergency use authorization, the treating doctor has to obtain a written consent from the patient.

The company said in a statement, “Glenmark has successfully developed the API and the formulation for FabiFlu® through its own in-house R&D [research and development] team within the country, ensuring self-reliance with regard to long-term production and manufacturing. The API is manufactured at the Gujarat production facility which is USFDA & MHRA–UK approved. The formulation product is manufactured at the facility in Himachal Pradesh, which is also USFDA and MHRA-UK approved.”

Glenmark said it is also conducting another clinical trial for a combination therapy using antiviral drugs Favipiravir and Umifenovir in moderate hospitalised cases.

Previous Files

Custom Search